Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-04-000816
Filing Date
2004-03-15
Accepted
2004-03-12 21:44:32
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tenk.txt 10-K 443224
3 EXHIBIT 10.64 ex10-64.txt EX-10 38133
4 EXHIBIT 10.65 ex10-65.txt EX-10 4564
5 EXHIBIT 14.1 ex14-1.txt EX-14 2248
6 EXHIBIT 23.1 ex23-1.txt EX-23 549
7 EXHIBIT 23.2 ex23-2.txt EX-23 639
8 EXHIBIT 31.1 ex31-1.txt EX-31 4051
9 EXHIBIT 31.2 ex31-2.txt EX-31 4052
10 EXHIBIT 32.1 ex32-1.txt EX-32 1500
11 EXHIBIT 32.2 ex32-2.txt EX-32 1510
  Complete submission text file 0000950116-04-000816.txt   503030
Mailing Address CASTOR & KENSINGTON AVENUES PHILADELPHIA PA 19124-5694
Business Address 30831 HAYWARD AVE HAYWARD CA 94544 2152892220
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27354 | Film No.: 04667554
SIC: 2834 Pharmaceutical Preparations